Your browser doesn't support javascript.
loading
Association between use of antipyretics and antibody titers after two doses of the BNT162b2 SARS-CoV-2 vaccine in adolescents and young adults with underlying diseases.
Aiba, Hiroyuki; Funaki, Takanori; Yamada, Masaki; Miyake, Kozue; Ueno, Saki; Tao, Chiaki; Myojin, Shota; Matsui, Toshihiro; Ogimi, Chikara; Kato, Hitoshi; Miyairi, Isao; Shoji, Kensuke.
Afiliação
  • Aiba H; Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan.
  • Funaki T; Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan.
  • Yamada M; Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan; Department for Advanced Medicine for Viral Infections, National Center for Child Health and Development, Tokyo, Japan.
  • Miyake K; Department of Clinical Research Promotion, National Center for Child Health and Development, Tokyo, Japan.
  • Ueno S; Department of Clinical Research Promotion, National Center for Child Health and Development, Tokyo, Japan.
  • Tao C; Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan.
  • Myojin S; Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan.
  • Matsui T; Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan.
  • Ogimi C; Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan.
  • Kato H; National Center for Child Health and Development, Tokyo, Japan.
  • Miyairi I; Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan; Department of Pediatrics, Hamamatsu University School of Medicine, Shizuoka, Japan.
  • Shoji K; Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan. Electronic address: shoji-k@ncchd.go.jp.
J Infect Chemother ; 30(2): 176-178, 2024 Feb.
Article em En | MEDLINE | ID: mdl-37769991
There are few reports on the association between antipyretic use and antibody titers in adolescents and young adults following SARS-CoV-2 vaccination. Multivariable linear regression analyses were performed to examine the association between antipyretic use and antibody titers. The use of antipyretics was not associated with antibody titers (ß coefficient [95% CI] = -0.107 [-0.438 to 0.224]).
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antipiréticos / COVID-19 Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antipiréticos / COVID-19 Idioma: En Ano de publicação: 2024 Tipo de documento: Article